Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma - Motzer, RJ; Tannir, NM; McDermott, DF; Arén Frontera, O; Melichar, B; Choueiri, TK; CheckMate 214 Investigators (N Engl J Med, 2018)